Targeting the NUDT16-HMGA1 pathway exacerbated replication pressure and reduced the stability of stalled replication forks, ultimately improving the sensitivity of hepatocellular carcinoma cells to chemotherapy and IR treatment. Here, NUDT16 is linked to hepatocellular carcinoma.